
Crescel
Crescel is a science and technology company developing biobotanical technology for health.

Crescel is a science and technology company developing biobotanical technology for health.
crescel.comCrawled Oct 27, 2026
Food for the skin fine-tuned to the optimal metabolic function of the mitochondria and the cells they govern. The product also provides hydrators to bind water to the skin, along with moisturizers containing oils that help to lock it in.
Dr. Roberta Shapiro, DO from Columbia University, discusses Crescel’s transformative clinical patient cases for multiple skin conditions including bedsores.
Crescel Skin Renewal Cream clears eczema for a woman who has suffered from the condition since childhood.
Superior results from a randomized, blinded, and controlled clinical trial in rosacea comparing Crescel to the standard of care, 0.75% Metronidazole Cream (MetroCream) combined with a moisturizer.
The company combines natural and scientific approaches to develop skin-healing products.
Crescel LLC’s Privacy Policy explains how the company collects, uses, and protects personal information from website visitors and customers.
The company sells Crescel products with no returns or exchanges.
The company provides free standard shipping on all orders in the United States, with shipping charges calculated at checkout based on delivery method and location. Orders placed by 2pm ET ship the same day, excluding weekends and holidays.
Crescel LLC publishes a peer-reviewed clinical study in the *Journal of Cosmetic Dermatology* demonstrating its biobotanical technology yields statistically significant improvements over the leading prescription treatment for rosacea. The randomized, double-blind trial—indexed on PubMed—marks a key validation of the company’s proprietary approach in dermatological care.
Jul 2026Yahoo FinanceNews article
A double-blinded, randomized trial assesses a botanical-based topical moisturizer for treating rosacea-related facial erythema. The study evaluates its efficacy, tolerability, and safety compared to standard treatments. Researchers measure improvements in skin inflammation and patient-reported outcomes over a defined period. Preliminary findings suggest potential benefits for managing resistant rosacea symptoms.
May 2026Journal of Cosmetic DermatologyNews article
Crescel LLC announces positive results from a double-blind, randomized trial comparing its **biobotanical Skin Renewal Cream** to a standard rosacea treatment—**topical metronidazole (Metrocream®) combined with CeraVe® moisturizer**. The study evaluates efficacy in individuals with **rosacea**, a chronic inflammatory skin condition. Crescel’s cream demonstrates comparable performance in clinical testing.
Mar 2026Yahoo FinanceNews article
Crescel demonstrates superior clinical improvement in trials compared to the standard metronidazole-based treatment. The new therapy also shows favorable tolerability, suggesting potential advantages over existing options. The study highlights Crescel’s progress in developing alternatives for conditions where metronidazole is commonly used.
Mar 2026Yonhap News AgencyNews article